Shared findings, papers, and results from the research community
This space is for researchers to share results and important papers related to peptides and longevity science. Community submissions will appear here as they are reviewed. Until then, we surface recent peer-reviewed and pilot literature on BPC-157 for educational discussion.
For research discussion only. These compounds and citations are not medical advice. Products offered by PepStep are for research use only (RUO), not for human or veterinary use.
Narrative review of preclinical and limited human data on BPC-157 in musculoskeletal contexts. Notes robust animal evidence for regenerative effects and that human data remain limited to small pilot studies, with no large-scale controlled trials.
View PaperSystematic review of English-language literature through mid-2024. Included 36 studies (35 preclinical, 1 clinical). Discusses growth hormone receptor expression, angiogenesis pathways, inflammatory cytokine modulation, metabolism, and the current gap in high-quality human evidence.
View on PubMedBroad literature and patent review covering tissue injury, inflammatory models, CNS-related findings, safety profile considerations, and regulatory context. Emphasizes the need for comprehensive clinical studies.
View on PubMedSmall pilot evaluating intravenous BPC-157 in healthy adults. Reported as well tolerated in the limited cohort, with no major adverse events described in the available summary. One of the few published human safety/PK pilots.
Search PubMedMechanistic study examining how BPC-157 may influence angiogenesis via FBXO22 and BACH1 pathways, contributing to the molecular understanding of observed preclinical vascular and healing effects.
View PaperResearchers may submit papers, posters, or summaries for consideration. Submissions go to info@pepstepguide.com.
